Financials in USD. Standardized financial statements.
A compact view of how Wave Life Sciences Ltd. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $42.73M | $108.30M | $113.31M | $3.65M | $40.96M | $20.08M | $15.98M | $14.41M | $3.70M | $1.49M |
| Revenue Growth? | -60.5% | -4.4% | +3005.1% | -91.1% | +104.0% | +25.6% | +10.9% | +289.1% | +149.4% | 0.0% |
| Cost of Revenue? | $8.85M | $0 | $0 | $0 | $0 | $130.94M | $175.43M | $134.43M | $79.31M | $393,000 |
| Gross Profit? | $33.88M | $108.30M | $113.31M | $3.65M | $40.96M | -$110.87M | -$159.45M | -$120.01M | -$75.61M | $1.09M |
| Gross Margin? | +79.3% | +100.0% | +100.0% | +100.0% | +100.0% | -552.2% | -997.6% | -832.6% | -2041.2% | +73.5% |
| Operating Expenses? | $249.26M | $218.71M | $181.30M | $166.37M | $167.98M | $42.51M | $48.87M | $173.94M | $106.28M | $56.81M |
| Operating Income? | -$215.38M | -$110.40M | -$68.00M | -$162.72M | -$127.02M | -$153.38M | -$208.32M | -$159.52M | -$102.58M | -$55.33M |
| EBITDA? | -$195.53M | -$101.74M | -$58.79M | -$152.61M | -$117.18M | -$145.26M | -$200.73M | -$153.94M | -$100.24M | -$54.94M |
| Income Before Tax | -$204.38M | -$97.01M | -$58.19M | -$161.14M | -$122.45M | -$150.75M | -$193.64M | -$146.58M | -$101.33M | -$54.78M |
| Income Tax Expense | $0 | $0 | -$677,000 | $681,000 | -$204,000 | -$841,000 | $0 | $69,000 | $708,000 | $616,000 |
| Net Income? | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M | -$149.91M | -$193.64M | -$146.65M | -$102.03M | -$55.40M |
| EPS? | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | $-3.82 | $-5.30 | $-5.06 | $-3.85 | $-2.43 |
| Diluted EPS? | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | $-3.82 | $-5.30 | $-5.06 | $-3.85 | $-2.43 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality